Journal
ALZHEIMERS & DEMENTIA
Volume 16, Issue 2, Pages 273-282Publisher
WILEY
DOI: 10.1016/j.jalz.2019.09.002
Keywords
Alzheimer's disease; Amyloid hypothesis; C99; Proximity-ligation assay; beta-amyloid; bCTF
Categories
Funding
- Fisher Center for Alzheimer's Research Foundation
- Cure Alzheimer's Fund
- JPB Grant [794]
- DOD/USAMRAA [W81XWH-14-1-0045]
Ask authors/readers for more resources
Introduction: The levels and distribution of amyloid deposits in the brain does not correlate well with Alzheimer's disease (AD) progression. Therefore, it is likely thatamyloid precursor protein and its proteolytic fragments other than amyloid b (Ab) contribute to the onset of AD. Methods: We developed a sensitive assay adapted to the detection of C99, the direct precursor of b-amyloid. Three postmortem groups were studied: control with normal and stable cognition; patients with moderate AD, and individuals with severe AD. The amount of C99 and A beta was quantified and correlated with the severity of AD. Results: C99 accumulates in vulnerable neurons, and its levels correlate with the degree of cognitive impairment in patients suffering from AD. In contrast, A beta levels are increased in both vulnerable and resistant brain areas. Discussion: These results raise the possibility that C99, rather than A beta plaques, is responsible for the death of nerve cells in AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available